Study on tolerance of Yanshen oral solution in phase Ⅰ clinical trials
Yan Benyong,Zhang Feng,Sun Li,Liang Juncheng,Fan Huaying,Shi Jie,Xu Guozhu,Deng Yanping
DOI: https://doi.org/10.3969/j.issn.1008-5734.2011.03.001
2011-01-01
Abstract:Objective:To study the tolerance of Yanshen oral solution and to determine its safe dosage.Methods:A total of 38 healthy volunteers(aged 18-32 years) entered the tolerance study and received a single-dose regimen or a multi-dose regimen in clinical trials.The single-dose regimen was an open study,26 subjects were divided into 5 groups:the 5 ml dose group(n=4),the 10 ml dose group(n=4),the 20 ml dose group(n=6),the 30 ml dose group(n=6),and the 40 ml dose group(n=6).The multiple-dose regimen was a randomized,double-blinded,and placebo-controlled study,12 subjects were divided into 2 groups;the Yanshen group(n=6) and the placebo group(n=6).The ratio of male to female in each group was 1 to 1.During the study period, the subjects' vital signs and adverse events were observed and recorded;routine blood,urine,and stool tests,blood biochemical tests (including the levels of K~+,Na~+,Ca~(2+),Cl~-,glutamic-pyruvic transaminase,aspartate aminotransferase,total bilirubin,alkaline phosphatase,urea nitrogen,creatinine,etc.),and electrocardiogram(ECG) were performed and all the results were statistically analyzed.Results:There were no differences in the age,gender,body weight and height among the 4 single-dose groups(the 40 ml dose group was canceled because of intolerance) and between the 2 multiple-dose groups.The maximum tolerance dose was 30 ml in the single-dose regimen and 20 subjects completed the study.A dose of 20 ml thrice daily for 7 consecutive days was selected for the multiple-dose regimen study.There were no statistically significant changes in vital signs,the routine blood,urine,and stool tests, and blood biochemical tests in all subjects after receiving the single-dose or multiple dose regimens.In the single-dose regimen study, sinus bradycardia occurred in 1 subject each in the 20 ml dose and 30 ml dose groups.All subjects receiving the multi-dose regimen had normal ECG.The main adverse reactions after drug administration were mild nausea and vomiting.In the single-dose regimen study,nausea occurred in 1 subject in the 5 ml dose group and 3 subjects in the 20 ml dose group,vomiting occurred in 1 subject in the 5 ml dose group and 2 subjects in the 20 ml dose group;in addition,all 6 subjects in the 30 ml dose group developed nausea and vomiting.In the multiple-dose regimen study,mild nausea and vomiting occurred in 2 subjects in the Yanshen group;however,the symptoms improved 30 min after developing adverse reactions.Conclusion:Yanshen oral solution could be well tolerated in a dose of 20 ml thrice daily with no severe adverse reactions.